Skip to main content

Advertisement

Log in

Type 1 Diabetes and Celiac Disease: Clinical Overlap and New Insights into Disease Pathogenesis

  • Diabetes and Other Diseases-Emerging Associations (JJ Nolan, Section Editor)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Type 1 diabetes (T1D) and celiac disease (CD) are autoimmune diseases with clinical and pathogenic overlap. The mean prevalence of CD in patients with T1D is about 8 %. Classic intestinal symptoms of CD may not be present in T1D leading to the recommendation for active case finding in this higher risk group. Screening is done with sensitive and specific serologies including tissue transglutaminase (tTG) IgA and deaminated gliadin peptide (DGP) IgA and IgG. Positive serologies are confirmed by the presence of villous atrophy and increased intraepithelial lymphocytes on duodenal biopsy. A strict gluten free diet is recommended, although this can pose challenges for T1D patients who already have dietary restrictions. In aggregate, it appears as if the gluten free diet may help T1D management. T1D and CD have overlapping genetic and environmental risk factors. Among these, non-HLA genetic factors and the gut microbiome are among recent developments that will be discussed in this review.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Dabelea D. The accelerating epidemic of childhood diabetes. Lancet. 2009;373:1999–2000. An excellent review on the increasing incidence of type 1 diabetes.

    Article  PubMed  Google Scholar 

  2. Fasano A, Catassi C. Clinical practice. Celiac disease. N Engl J Med. 2012;367:2419–26.

    Article  CAS  PubMed  Google Scholar 

  3. Kang JY, Kang AH, Green A, Gwee KA, Ho KY. Systematic review: worldwide variation in the frequency of coeliac disease and changes over time. Aliment Pharmacol Ther. 2013;38:226–45. An up-to-date review on celiac disease and worldwide variation.

    Article  CAS  PubMed  Google Scholar 

  4. Dube C, Rostom A, Sy R, Cranney A, Saloojee N, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology. 2005;128:S57–67.

    Article  PubMed  Google Scholar 

  5. Gillett PM, Gillett HR, Israel DM, Metzger DL, Stewart L, et al. High prevalence of celiac disease in patients with type 1 diabetes detected by antibodies to endomysium and tissue transglutaminase. Can J Gastroenterol. 2001;15:297–301.

    CAS  PubMed  Google Scholar 

  6. Volta U, Tovoli F, Caio G. Clinical and immunological features of celiac disease in patients with Type 1 diabetes mellitus. Expert Rev Gastroenterol Hepatol. 2011;5:479–87. A comprehensive clinical review on celiac disease in patients with type 1 diabetes.

    Article  CAS  PubMed  Google Scholar 

  7. Kaistha A, Castells S. Celiac disease in African American children with type 1 diabetes mellitus in inner city Brooklyn. Pediatr Endocrinol Rev. 2008;5 Suppl 4:994–8.

    PubMed  Google Scholar 

  8. Green PH. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology. 2005;128:S74–8.

    Article  PubMed  Google Scholar 

  9. Reilly NR, Fasano A, Green PH. Presentation of celiac disease. Gastrointest Endosc Clin N Am. 2012;22:613–21.

    Article  PubMed  Google Scholar 

  10. Freemark M, Levitsky LL. Screening for celiac disease in children with type 1 diabetes: two views of the controversy. Diabetes Care. 2003;26:1932–9.

    Article  PubMed  Google Scholar 

  11. Holmes GK. Coeliac disease and Type 1 diabetes mellitus - the case for screening. Diabetes Med. 2001;18:169–77.

    Article  CAS  Google Scholar 

  12. Valerio G, Maiuri L, Troncone R, Buono P, Lombardi F, et al. Severe clinical onset of diabetes and increased prevalence of other autoimmune diseases in children with coeliac disease diagnosed before diabetes mellitus. Diabetologia. 2002;45:1719–22.

    Article  CAS  PubMed  Google Scholar 

  13. Ventura A, Neri E, Ughi C, Leopaldi A, Citta A, et al. Gluten-dependent diabetes-related and thyroid-related autoantibodies in patients with celiac disease. J Pediatr. 2000;137:263–5.

    Article  CAS  PubMed  Google Scholar 

  14. Narula P, Porter L, Langton J, Rao V, Davies P, et al. Gastrointestinal symptoms in children with type 1 diabetes screened for celiac disease. Pediatrics. 2009;124:e489–95.

    Article  PubMed  Google Scholar 

  15. Cerutti F, Bruno G, Chiarelli F, Lorini R, Meschi F, et al. Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: an Italian multicenter study. Diabetes Care. 2004;27:1294–8.

    Article  PubMed  Google Scholar 

  16. Camarca ME, Mozzillo E, Nugnes R, Zito E, Falco M, et al. Celiac disease in type 1 diabetes mellitus. Ital J Pediatr. 2012;38:10.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Damen GM, Boersma B, Wit JM, Heymans HS. Catch-up growth in 60 children with celiac disease. J Pediatr Gastroenterol Nutr. 1994;19:394–400.

    Article  CAS  PubMed  Google Scholar 

  18. Kordonouri O, Maguire AM, Knip M, Schober E, Lorini R, et al. ISPAD Clinical Practice Consensus Guidelines 2006-2007. Other complications and associated conditions. Pediatr Diabetes. 2007;8:171–6.

    Article  PubMed  Google Scholar 

  19. Husby S, Koletzko S, Korponay-Szabo IR, Mearin ML, Phillips A, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–60. Society guidelines on screening and diagnosis of celiac disease recommending screening of patients with type 1 diabetes.

    Article  CAS  PubMed  Google Scholar 

  20. Leffler DA, Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol. 2010;105:2520–4.

    Article  PubMed  Google Scholar 

  21. Waisbourd-Zinman O, Hojsak I, Rosenbach Y, Mozer-Glassberg Y, Shalitin S, et al. Spontaneous normalization of anti-tissue transglutaminase antibody levels is common in children with type 1 diabetes mellitus. Dig Dis Sci. 2012;57:1314–20. Recent study that found over 30% of type 1 diabetes patients normalize celiac disease serologies while on a gluten free diet.

    Article  CAS  PubMed  Google Scholar 

  22. Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131:1981–2002.

    Article  PubMed  Google Scholar 

  23. Chand N, Mihas AA. Celiac disease: current concepts in diagnosis and treatment. J Clin Gastroenterol. 2006;40:3–14.

    Article  PubMed  Google Scholar 

  24. Miranda J, Lasa A, Bustamante MA, Churruca I, Simon E. Nutritional differences between a gluten-free diet and a diet containing equivalent products with gluten. Plant Foods Hum Nutr. 2014;69(2):182–187.

  25. Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656–76. quiz 677. American society guidelines for screening and diagnosis of celiac disease recommending active case finding of celiac disease in individuals with type 1 diabetes.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Bakker SF, Pouwer F, Tushuizen ME, Hoogma RP, Mulder CJ, et al. Compromised quality of life in patients with both Type 1 diabetes mellitus and coeliac disease. Diabetes Med. 2013;30:835–9.

    Article  CAS  Google Scholar 

  27. Mollazadegan K, Sanders DS, Ludvigsson J, Ludvigsson JF. Long-term coeliac disease influences risk of death in patients with type 1 diabetes. J Intern Med. 2013;274:273–80. This large Swedish study found with both celiac and type 1 diabetes in patients with >15 years of diabetes increases risk of death 2.8 fold.

    Article  CAS  PubMed  Google Scholar 

  28. Leeds JS, Hopper AD, Hadjivassiliou M, Tesfaye S, Sanders DS. High prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac disease. Diabetes Care. 2011;34:2158–63.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Amin R, Murphy N, Edge J, Ahmed ML, Acerini CL, et al. A longitudinal study of the effects of a gluten-free diet on glycemic control and weight gain in subjects with type 1 diabetes and celiac disease. Diabetes Care. 2002;25:1117–22.

    Article  PubMed  Google Scholar 

  30. Scaramuzza AE, Mantegazza C, Bosetti A, Zuccotti GV. Type 1 diabetes and celiac disease: the effects of gluten free diet on metabolic control. World J Diabetes. 2013;4:130–4.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Krolewski AS, Warram JH, Rand LI, Kahn CR. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med. 1987;317:1390–8.

    Article  CAS  PubMed  Google Scholar 

  32. Noble JA, Erlich HA. Genetics of type 1 diabetes. Cold Spring Harb Perspect Med. 2012;2:a007732. Up-to-date review of genetic discoveries in type 1 diabetes.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Hermann R, Turpeinen H, Laine AP, Veijola R, Knip M, et al. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens. 2003;62:162–9.

    Article  CAS  PubMed  Google Scholar 

  34. Sollid LM, Jabri B. Is celiac disease an autoimmune disorder? Curr Opin Immunol. 2005;17:595–600.

    Article  CAS  PubMed  Google Scholar 

  35. Kumar V, Wijmenga C, Withoff S. From genome-wide association studies to disease mechanisms: celiac disease as a model for autoimmune diseases. Semin Immunopathol. 2012;34:567–80. Recent review on genetic associations in celiac and type 1 diabetes.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med. 2008;359:2767–77.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. Knip M, Simell O. Environmental triggers of type 1 diabetes. Cold Spring Harb Perspect Med. 2012;2:a007690. Recent review of environmental risk factors in type 1 diabetes.

    Article  PubMed Central  PubMed  Google Scholar 

  38. Kupfer SS, Jabri B. Pathophysiology of celiac disease. Gastrointest Endosc Clin N Am. 2012;22:639–60.

    Article  PubMed  Google Scholar 

  39. Norris JM, Barriga K, Klingensmith G, Hoffman M, Eisenbarth GS, et al. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA. 2003;290:1713–20.

    Article  CAS  PubMed  Google Scholar 

  40. Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA. 2003;290:1721–8.

    Article  CAS  PubMed  Google Scholar 

  41. Norris JM, Barriga K, Hoffenberg EJ, Taki I, Miao D, et al. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA. 2005;293:2343–51.

    Article  CAS  PubMed  Google Scholar 

  42. Virtanen SM, Knip M. Nutritional risk predictors of beta cell autoimmunity and type 1 diabetes at a young age. Am J Clin Nutr. 2003;78:1053–67.

    CAS  PubMed  Google Scholar 

  43. Akobeng AK, Ramanan AV, Buchan I, Heller RF. Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch Dis Child. 2006;91:39–43.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  44. Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ. 2011;342:d35.

    Article  PubMed Central  PubMed  Google Scholar 

  45. Stene LC, Oikarinen S, Hyoty H, Barriga KJ, Norris JM, et al. Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes. 2010;59:3174–80.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Stene LC, Honeyman MC, Hoffenberg EJ, Haas JE, Sokol RJ, et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol. 2006;101:2333–40.

    Article  CAS  PubMed  Google Scholar 

  47. Zanoni G, Navone R, Lunardi C, Tridente G, Bason C, et al. In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med. 2006;3:e358.

    Article  PubMed Central  PubMed  Google Scholar 

  48. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, et al. The human microbiome project. Nature. 2007;449:804–10.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  49. Bach JF. Six questions about the hygiene hypothesis. Cell Immunol. 2005;233:158–61.

    Article  CAS  PubMed  Google Scholar 

  50. von Herrath MG, Fujinami RS, Whitton JL. Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol. 2003;1:151–7.

    Article  Google Scholar 

  51. Rook GA, Adams V, Hunt J, Palmer R, Martinelli R, et al. Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders. Springer Semin Immunopathol. 2004;25:237–55.

    Article  CAS  PubMed  Google Scholar 

  52. Vaarala O, Atkinson MA, Neu J. The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes. 2008;57:2555–62.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  53. Atkinson MA, Chervonsky A. Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia. 2012;55:2868–77. Recent review of the gut microbiome and development of type 1 diabetes.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  54. King C, Sarvetnick N. The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions. PLoS One. 2011;6:e17049.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  55. McInerney MF, Pek SB, Thomas DW. Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice. Diabetes. 1991;40:715–25.

    Article  CAS  PubMed  Google Scholar 

  56. Satoh J, Shintani S, Oya K, Tanaka S, Nobunaga T, et al. Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats. Diabetes. 1988;37:1188–94.

    Article  CAS  PubMed  Google Scholar 

  57. Valladares R, Sankar D, Li N, Williams E, Lai KK, et al. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One. 2010;5:e10507.

    Article  PubMed Central  PubMed  Google Scholar 

  58. Lau K, Benitez P, Ardissone A, Wilson TD, Collins EL, et al. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J Immunol. 2011;186:3538–46.

    Article  CAS  PubMed  Google Scholar 

  59. Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science. 2013;339:1084–88.

    Article  CAS  PubMed  Google Scholar 

  60. Lee AS, Gibson DL, Zhang Y, Sham HP, Vallance BA, et al. Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia. 2010;53:741–8.

    Article  CAS  PubMed  Google Scholar 

  61. Marietta EV, Gomez AM, Yeoman C, Tilahun AY, Clark CR, et al. Low incidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome. PLoS One. 2013;8:e78687. Marietta and colleagues compared the effect of feeding a gluten free diet and gluten containing diet on the microbiome and incidence of hyperglycemia in NOD mice and found a reduced rate of hyperglycemia while on the gluten free diet.

    Article  PubMed Central  PubMed  Google Scholar 

  62. Soyucen E, Gulcan A, Aktuglu-Zeybek AC, Onal H, Kiykim E, et al. Differences in the gut microbiota of healthy children and those with type 1 diabetes. Pediatr Int. 2013;56(3):336–343.

  63. Giongo A, Gano KA, Crabb DB, Mukherjee N, Novelo LL, et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 2011;5:82–91.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  64. de Goffau MC, Luopajarvi K, Knip M, Ilonen J, Ruohtula T, et al. Fecal microbiota composition differs between children with beta-cell autoimmunity and those without. Diabetes. 2013;62:1238–44.

    Article  PubMed Central  PubMed  Google Scholar 

  65. Murri M, Leiva I, Gomez-Zumaquero JM, Tinahones FJ, Cardona F, et al. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med. 2013;11:46.

    Article  PubMed Central  PubMed  Google Scholar 

  66. Laparra JM, Olivares M, Gallina O, Sanz Y. Bifidobacterium longum CECT 7347 modulates immune responses in a gliadin-induced enteropathy animal model. PLoS One. 2012;7:e30744.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  67. Papista C, Gerakopoulos V, Kourelis A, Sounidaki M, Kontana A, et al. Gluten induces coeliac-like disease in sensitised mice involving IgA, CD71 and transglutaminase 2 interactions that are prevented by probiotics. Lab Invest. 2012;92:625–35.

    Article  CAS  PubMed  Google Scholar 

  68. D'Arienzo R, Stefanile R, Maurano F, Mazzarella G, Ricca E, et al. Immunomodulatory effects of Lactobacillus casei administration in a mouse model of gliadin-sensitive enteropathy. Scand J Immunol. 2011;74:335–41.

    Article  PubMed  Google Scholar 

  69. Cinova J, De Palma G, Stepankova R, Kofronova O, Kverka M, et al. Role of intestinal bacteria in gliadin-induced changes in intestinal mucosa: study in germ-free rats. PLoS One. 2011;6:e16169.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  70. Sanchez E, Donat E, Ribes-Koninckx C, Fernandez-Murga ML, Sanz Y. Duodenal-mucosal bacteria associated with celiac disease in children. Appl Environ Microbiol. 2013;79:5472–9.

    Article  PubMed Central  PubMed  Google Scholar 

  71. Sanchez E, Ribes-Koninckx C, Calabuig M, Sanz Y. Intestinal Staphylococcus spp. and virulent features associated with coeliac disease. J Clin Pathol. 2012;65:830–4.

    Article  CAS  PubMed  Google Scholar 

  72. Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol. 2009;62:264–9.

    Article  CAS  PubMed  Google Scholar 

  73. Nadal I, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol. 2007;56:1669–74.

    Article  CAS  PubMed  Google Scholar 

  74. De Palma G, Nadal I, Medina M, Donat E, Ribes-Koninckx C, et al. Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol. 2010;10:63.

    Article  PubMed Central  PubMed  Google Scholar 

  75. Cheng J, Kalliomaki M, Heilig HG, Palva A, Lahteenoja H, et al. Duodenal microbiota composition and mucosal homeostasis in pediatric celiac disease. BMC Gastroenterol. 2013;13:113.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  76. Wacklin P, Kaukinen K, Tuovinen E, Collin P, Lindfors K, et al. The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease. Inflamm Bowel Dis. 2013;19:934–41.

    Article  PubMed  Google Scholar 

  77. Schippa S, Iebba V, Barbato M, Di Nardo G, Totino V, et al. A distinctive 'microbial sigNature.' in celiac pediatric patients. BMC Microbiol. 2010;10:175.

    Article  PubMed Central  PubMed  Google Scholar 

  78. Caminero A, Herran AR, Nistal E, Perez-Andres J, Vaquero L, et al. Diversity of the cultivable human gut microbiome involved in gluten metabolism: isolation of microorganisms with potential interest for coeliac disease. FEMS Microbiol Ecol. 2014;88(2):309–319.

  79. Sanchez E, Nadal I, Donat E, Ribes-Koninckx C, Calabuig M, et al. Reduced diversity and increased virulence-gene carriage in intestinal enterobacteria of coeliac children. BMC Gastroenterol. 2008;8:50.

    Article  PubMed Central  PubMed  Google Scholar 

  80. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139:485–98.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  81. Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, Mulder I, Lan A, et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity. 2009;31:677–89.

    Article  CAS  PubMed  Google Scholar 

  82. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature. 2008;455:1109–13.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  83. Sorini C, Falcone M. Shaping the (auto)immune response in the gut: the role of intestinal immune regulation in the prevention of type 1 diabetes. Am J Clin Exp Immunol. 2013;2:156–71.

    PubMed Central  PubMed  Google Scholar 

  84. Fernandez S, Molina IJ, Romero P, Gonzalez R, Pena J, et al. Characterization of gliadin-specific Th17 cells from the mucosa of celiac disease patients. Am J Gastroenterol. 2011;106:528–38.

    Article  CAS  PubMed  Google Scholar 

  85. Boudraa G, Hachelaf W, Benbouabdellah M, Belkadi M, Benmansour FZ, et al. Prevalence of coeliac disease in diabetic children and their first- degree relatives in west Algeria: screening with serological markers. Acta Paediatr. 1996;412(Suppl):58–60.

    Article  CAS  Google Scholar 

  86. Peretti N, Bienvenu F, Bouvet C, Fabien N, Tixier F, et al. The temporal relationship between the onset of type 1 diabetes and celiac disease: a study based on immunoglobulin a antitransglutaminase screening. Pediatrics. 2004;113:e418–22.

    Article  PubMed  Google Scholar 

  87. Mahmud FH, Murray JA, Kudva YC, Zinsmeister AR, Dierkhising RA, et al. Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features. Mayo Clin Proc. 2005;80:1429–34.

    Article  PubMed Central  PubMed  Google Scholar 

  88. Frohlich-Reiterer EE, Hofer S, Kaspers S, Herbst A, Kordonouri O, et al. Screening frequency for celiac disease and autoimmune thyroiditis in children and adolescents with type 1 diabetes mellitus—data from a German/Austrian multicentre survey. Pediatr Diabetes. 2008;9:546–53.

    Article  PubMed  Google Scholar 

  89. Salardi S, Volta U, Zucchini S, Fiorini E, Maltoni G, et al. Prevalence of celiac disease in children with type 1 diabetes mellitus increased in the mid-1990s: an 18-year longitudinal study based on anti-endomysial antibodies. J Pediatr Gastroenterol Nutr. 2008;46:612–4.

    Article  PubMed  Google Scholar 

  90. Uibo O, Heilman K, Rago T, Shor R, Paal M, et al. Symptomless celiac disease in type 1 diabetes: 12-year experience in Estonia. Pediatr Int. 2010;52:230–3.

    Article  PubMed  Google Scholar 

  91. Fallahi GH, Ahmadian JH, Rabbani A, Yousefnezhad AS, Rezaei N. Screening for celiac disease in diabetic children from Iran. Indian Pediatr. 2010;47:268–70.

    Article  PubMed  Google Scholar 

  92. Djuric Z, Stamenkovic H, Stankovic T, Milicevic R, Brankovic L, et al. Celiac disease prevalence in children and adolescents with type 1 diabetes from Serbia. Pediatr Int. 2010;52:579–83.

    Article  PubMed  Google Scholar 

  93. Bhadada SK, Kochhar R, Bhansali A, Dutta U, Kumar PR, et al. Prevalence and clinical profile of celiac disease in type 1 diabetes mellitus in north India. J Gastroenterol Hepatol. 2011;26:378–81.

    Article  PubMed  Google Scholar 

  94. Hanukoglu A, Mizrachi A, Dalal I, Admoni O, Rakover Y, et al. Extrapancreatic autoimmune manifestations in type 1 diabetes patients and their first-degree relatives: a multicenter study. Diabetes Care. 2003;26:1235–40.

    Article  PubMed  Google Scholar 

  95. Sari S, Yesilkaya E, Egritas O, Bideci A, Cinaz P, et al. Prevalence of Celiac disease in Turkish children with type 1 diabetes mellitus and their non-diabetic first-degree relatives. Turk J Gastroenterol. 2010;21:34–8.

    PubMed  Google Scholar 

  96. van der Windt DA, Jellema P, Mulder CJ, Kneepkens CM, van der Horst HE. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA. 2010;303:1738–46. Excellent review of diagnostic testing strategies for celiac disease.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Aaron Cohn, M. Anthony Sofia, and Sonia S. Kupfer declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sonia S. Kupfer.

Additional information

This article is part of the Topical Collection on Diabetes and Other Diseases-Emerging Associations

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cohn, A., Sofia, A.M. & Kupfer, S.S. Type 1 Diabetes and Celiac Disease: Clinical Overlap and New Insights into Disease Pathogenesis. Curr Diab Rep 14, 517 (2014). https://doi.org/10.1007/s11892-014-0517-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11892-014-0517-x

Keywords

Navigation